Trials / Suspended
SuspendedNCT01929239
Trial of Anti-PSMA Designer T Cells in Advanced Prostate Cancer After Non-Myeloablative Conditioning
Phase Ia/Ib Trial of Anti-PSMA Designer T Cells in Prostate Cancer After Non-Myeloablative Conditioning
- Status
- Suspended
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 12 (estimated)
- Sponsor
- Roger Williams Medical Center · Academic / Other
- Sex
- Male
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is a Phase Ib Pilot study of anti-PSMA designer T cells in metastatic prostate cancer. Subjects will receive escalating doses of T cells, with either low or moderate dose Interleukin 2. The T cells are collected by pheresis and then genetically modified, and given in a one time infusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Anti-PSMA Designer T Cells |
Timeline
- Start date
- 2006-03-01
- Primary completion
- 2017-12-01
- Completion
- 2018-12-01
- First posted
- 2013-08-27
- Last updated
- 2016-06-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01929239. Inclusion in this directory is not an endorsement.